Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis

Open access
Priego, Neibla, Zhu, Lucía, Monteiro, Cátia, Mulders, Manon, Wasilewski, David, Bindeman, Wendy, Doglio, Laura, Martínez, Liliana, Martínez-Saez, Elena, Ramón y Cajal, Santiago, Megías, Diego, Hernández-Encinas, Elena, Blanco-Aparicio, Carmen, Martínez, Lola, Zarzuela, Eduardo, Muñoz, Javier, Fustero-Torre, Coral, Piñeiro-Yáñez, Elena, Hernández-Laín, Aurelio, Bertero, Luca, Poli, Valeria, Sanchez-Martinez, Melchor, Menendez, Javier A., Soffietti, Riccardo, Bosch-Barrera, Joaquim, Valiente, Manuel · 2018 · Nature Medicine

Abstract

The brain microenvironment imposes a particularly intense selective pressure on metastasis-initiating cells, but successful metastases bypass this control through mechanisms that are poorly understood. Reactive astrocytes are key components of this microenvironment that confine brain metastasis without infiltrating the lesion. Here, we describe that brain metastatic cells induce and maintain the co-option of a pro-metastatic program driven by signal transducer and activator of transcription 3 (STAT3) in a subpopulation of reactive astrocytes surrounding metastatic lesions. These reactive astrocytes benefit metastatic cells by their modulatory effect on the innate and acquired immune system. In patients, active STAT3 in reactive astrocytes correlates with reduced survival from diagnosis of intracranial metastases. Blocking STAT3 signaling in reactive astrocytes reduces experimental brain metastasis from different primary tumor sources, even at advanced stages of colonization. We also show that a safe and orally bioavailable treatment that inhibits STAT3 exhibits significant antitumor effects in patients with advanced systemic disease that included brain metastasis. Responses to this therapy were notable in the central nervous system, where several complete responses were achieved. Given that brain metastasis causes substantial morbidity and mortality, our results identify a novel treatment for increasing survival in patients with secondary brain tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-018-0044-4

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Cited by

See all 474

Metadata

Authors
Priego, N., Zhu, L., Monteiro, C., Mulders, M., Wasilewski, D., Bindeman, W., Doglio, L., Martínez, L., Martínez-Saez, E., Ramón y Cajal, S., Megías, D., Hernández-Encinas, E., Blanco-Aparicio, C., Martínez, L., Zarzuela, E., Muñoz, J., Fustero-Torre, C., Piñeiro-Yáñez, E., Hernández-Laín, A., Bertero, L., Poli, V., Sanchez-Martinez, M., Menendez, J. A., Soffietti, R., Bosch-Barrera, J., & Valiente, M.
Affiliations
  • Spanish National Cancer Research Centre (ES)
  • King's College London (GB)
  • University of Turin (IT)
Corresponding author
Valiente, Manuel
Venue
Nature Medicine
Published
2018-06-11
Volume
24
Issue
7
Pages
1024-1035
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2806597619
Cited by
452
References
67
Citations by year
2026: 49 · 2025: 61 · 2024: 68 · 2023: 73 · 2022: 51 · 2021: 51 · 2020: 49 · 2019: 39 · 2018: 11
FWCI
28.44
Type
journal article
Language
en
Open access
Licence
  • other-oa
  • www.springer.com/tdm (tdm)
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
Funders
  • Pfizer
  • Melanoma Research Alliance
  • Sociedad Española de Oncología Médica
  • Fundação para a Ciência e a Tecnologia (SFRH/BD/100089/2014)
Topics
  • Health Sciences › Medicine › Oncology › Brain Metastases and Treatment
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
STAT3, reactive astrocytes, brain metastases, tumor microenvironment, STAT3 inhibition, metastatic niche, immunomodulation, secondary brain tumors, metastasis-initiating cells
MeSH terms
Animals, Astrocytes, Brain, Brain Neoplasms, Cell Survival, Glial Fibrillary Acidic Protein, Humans, Immunity, Innate, Phosphorylation, Gene Targeting, STAT3 Transcription Factor, Mice, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis. https://app.cochat.ai/papers/10.1038/s41591-018-0044-4
The paper
Priego, N., Zhu, L., Monteiro, C., Mulders, M., Wasilewski, D., Bindeman, W., Doglio, L., Martínez, L., Martínez-Saez, E., Ramón y Cajal, S., Megías, D., Hernández-Encinas, E., Blanco-Aparicio, C., Martínez, L., Zarzuela, E., Muñoz, J., Fustero-Torre, C., Piñeiro-Yáñez, E., Hernández-Laín, A., . . . Valiente, M. (2018). STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis. Nature Medicine. https://doi.org/10.1038/s41591-018-0044-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.